Cargando…
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic
Despite recent advances, treatment options for advanced prostate cancer (CaP) remain limited. We are pioneering approaches to treat advanced CaP that employ conditionally replication-competent oncolytic adenoviruses that simultaneously produce a systemically active cancer-specific therapeutic cytoki...
Autores principales: | Sarkar, Siddik, Quinn, Bridget A., Shen, Xue-Ning, Dash, Rupesh, Das, Swadesh K., Emdad, Luni, Klibanov, Alexander L., Wang, Xiang-Yang, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484414/ https://www.ncbi.nlm.nih.gov/pubmed/25926554 |
Ejemplares similares
-
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2016) -
Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
por: Talukdar, Sarmistha, et al.
Publicado: (2016) -
Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis
por: Das, Swadesh K., et al.
Publicado: (2016) -
Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015) -
MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)